Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan

Kaida, Hayato; Kitajima, Kazuhiro; Nakajo, Masatoyo; Ishibashi, Mana; Matsunaga, Tomoyuki; Minamimoto, Ryogo; Hirata, Kenji; Nakatani, Kazuhiko; Hung, Ao; Hattori, Satoshi; Yasuda, Takushi; Ishii, Kazunari

doi:10.1007/s00259-021-05365-5

Eur J Nucl Med Mol Imaging

2021

DOI: 10.1007/s00259-021-05365-5

|View full text |Cite

Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan

Hayato Kaida

Kazuhiro Kitajima

Masatoyo Nakajo

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The prognostic value of pretreatment [18F]FDG PET/CT parameters in esophageal cancer: a meta-analysis

Huang,

Wang,

Wang

et al. 2024

Eur Radiol

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan

Cited by 4 publications

References 36 publications

The prognostic value of pretreatment [18F]FDG PET/CT parameters in esophageal cancer: a meta-analysis

The prognostic value of pretreatment [18F]FDG PET/CT parameters in esophageal cancer: a meta-analysis

Maximum standardized uptake value change rate before and after neoadjuvant chemotherapy can predict early recurrence in patients with locally advanced esophageal cancer: a multi-institutional cohort study of 220 patients in Japan

Valor pronóstico de los criterios PERCIST y los parámetros metabólicos de la PET/TC en pacientes con cáncer de esófago tras tratamiento neoadyuvante

Contact Info

Product

Resources

About